These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 24258355)

  • 21. Health-related quality of life evaluated by tumor node metastasis staging system in patients with hepatocellular carcinoma.
    Qiao CX; Zhai XF; Ling CQ; Lang QB; Dong HJ; Liu Q; Li MD
    World J Gastroenterol; 2012 Jun; 18(21):2689-94. PubMed ID: 22690079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depressive symptoms after treatment in hepatocellular carcinoma survivors: prevalence, determinants, and impact on health-related quality of life.
    Mikoshiba N; Miyashita M; Sakai T; Tateishi R; Koike K
    Psychooncology; 2013 Oct; 22(10):2347-53. PubMed ID: 23686523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptom clusters and symptom interference of HCC patients undergoing TACE: a cross-sectional study in China.
    Cao W; Li J; Hu C; Shen J; Liu X; Xu Y; Ye Z
    Support Care Cancer; 2013 Feb; 21(2):475-83. PubMed ID: 23010958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing the patients' subjective experiences of acute side effects during radiotherapy for head and neck cancer with four different patient-reported outcomes questionnaires.
    Holländer-Mieritz C; Johansen J; Johansen C; Vogelius IR; Kristensen CA; Pappot H
    Acta Oncol; 2019 May; 58(5):603-609. PubMed ID: 30698098
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of ginseng-based Renshenguben oral solution for cancer-related fatigue among patients with advanced-stage hepatocellular carcinoma: A prospective multicenter cohort study.
    Wang MD; Yuan C; Wang KC; Wang NY; Liang YJ; Zhu H; Tong XM; Yang T
    Hepatobiliary Pancreat Dis Int; 2024 Jun; 23(3):249-256. PubMed ID: 38040524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials. EORTC Study Group on Quality of Life.
    Bergman B; Aaronson NK; Ahmedzai S; Kaasa S; Sullivan M
    Eur J Cancer; 1994; 30A(5):635-42. PubMed ID: 8080679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life changes in patients undergoing treatment for hepatocellular carcinoma.
    Chie WC; Yu F; Li M; Baccaglini L; Blazeby JM; Hsiao CF; Chiu HC; Poon RT; Mikoshiba N; Al-Kadhimi G; Heaton N; Calara J; Collins P; Caddick K; Costantini A; Vilgrain V; Chiang C
    Qual Life Res; 2015 Oct; 24(10):2499-506. PubMed ID: 25943170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes in hepatocellular carcinoma patients undergoing sorafenib treatment: toxicities, cellular oxidative stress, treatment adherence, and quality of life.
    Baldan Ferrari G; Coelho França Quintanilha J; Berlofa Visacri M; Oliveira Vaz C; Cursino MA; Sampaio Amaral L; Brito Bastos ; Pereira TT; de Oliveira Guarnieri JP; de Godoy Torso N; Passos Lima CS; Moriel P
    Anticancer Drugs; 2020 Jun; 31(5):523-527. PubMed ID: 32107349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients With Hepatocellular Carcinoma Near the End of Life: A Longitudinal Qualitative Study of Their Illness Experiences.
    Hansen L; Rosenkranz SJ; Vaccaro GM; Chang MF
    Cancer Nurs; 2015; 38(4):E19-27. PubMed ID: 25122134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of life as a prognostic factor for survival in hepatocellular carcinoma.
    Sternby Eilard M; Hagström H; Mortensen KE; Wilsgaard T; Vagnildhaug OM; Dajani O; Stål P; Rizell M
    Liver Int; 2018 May; 38(5):885-894. PubMed ID: 28941130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent Fatigue in Patients With Hepatocellular Carcinoma Receiving Radiotherapy.
    Chen CY; Huang BS; Hong JH; Chang JT; Chen MC; Tang WR; Shun SC; Chen ML
    J Nurs Res; 2024 Apr; 32(2):e319. PubMed ID: 38506576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between anxiety disorders and domains of health related quality of life among Nigerians with breast cancer.
    Fatiregun OA; Olagunju AT; Erinfolami AR; Arogunmati OA; Fatiregun OA; Adeyemi JD
    Breast; 2017 Feb; 31():150-156. PubMed ID: 27866090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of hepatocellular carcinoma diagnosis on patients' health-related quality of life.
    Verma M; Paik JM; Younossi I; Tan D; Abdelaal H; Younossi ZM
    Cancer Med; 2021 Sep; 10(18):6273-6281. PubMed ID: 34405568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of the measure of ovarian symptoms and treatment concerns: aiming for optimal measurement of patient-reported symptom benefit with chemotherapy for symptomatic ovarian cancer.
    King MT; Stockler MR; Butow P; O'Connell R; Voysey M; Oza AM; Gillies K; Donovan HS; Mercieca-Bebber R; Martyn J; Sjoquist K; Friedlander ML
    Int J Gynecol Cancer; 2014 Jun; 24(5):865-73. PubMed ID: 24844220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of health-related quality of life after transarterial chemoembolization and transarterial radioembolization in patients with unresectable hepatocellular carcinoma.
    Kirchner T; Marquardt S; Werncke T; Kirstein MM; Brunkhorst T; Wacker F; Vogel A; Rodt T
    Abdom Radiol (NY); 2019 Apr; 44(4):1554-1561. PubMed ID: 30311050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the patient experience of locally advanced or metastatic pancreatic cancer to inform patient-reported outcomes assessment.
    Herman JM; Kitchen H; Degboe A; Aldhouse NVJ; Trigg A; Hodgin M; Narang A; Johnson CD
    Qual Life Res; 2019 Nov; 28(11):2929-2939. PubMed ID: 31273624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advanced hepatocellular carcinoma: A regional cancer center experience of 48 cases.
    Lokesh KN; Chaudhuri T; Lakshmaiah KC; Babu KG; Dasappa L; Jacob LA; Suresh Babu MC; Rudresha AH; Rajeev LK
    Indian J Cancer; 2017; 54(3):526-529. PubMed ID: 29798951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.